New Hampshire SB504 establishes experimental treatment centers for severe illnesses.
New Hampshire SB504 amends pharmacy practice laws to authorize experimental treatment centers for patients with terminal or severe illnesses. The bill allows licensed pharmacists to administer experimental treatments and mandates that these centers obtain authorization from the Department of Health and Human Services. It also provides immunity from suit for healthcare providers involved in such treatments if certain conditions are met.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.